PatientsMap

Portfolio Strategy and Market Analysis

Quantify market opportunities from estimated patient numbers and unmet medical needs (UMN), enabling high-confidence investment decisions and selection of focus areas.

Identifying the True Potential of Rare Diseases

Analyzing the correlation between disease rarity (patient numbers) and physician demand for new drugs. Identifying undiscovered "medical needs vacuums" to build evidence-based portfolio strategies.

Comprehensively comparing estimated patients across 400 diseases to analyze the potential for new drug administration. Objective market opportunity data enables precise market size forecasting and optimal resource allocation.

Using long-term time-series data from 2011 to analyze shifts in physician demand for new drugs. Visualizing structural changes between "satisfied needs" from breakthrough drugs and emerging "unmet needs" to identify the next development areas.

Read more →

Global Expansion and Area Analysis

Visualizing differences in market structure and unmet medical needs across countries, providing the foundation for decision-making in overseas expansion and region-specific approaches.

Identifying the True Potential of Rare Diseases (US Market)

Analyzing the correlation between disease rarity (patient numbers) and demand for new drugs in the US market. Identifying structural differences from the Japanese market and location-specific "medical needs vacuums" to build optimal portfolio strategies for US expansion.

Comparing changes in top diseases with new drug demand between Japan and the US over time. Visualizing persistent needs rooted in differing social backgrounds and trend changes driven by expectations for new drugs to build globally optimized strategies.

Comparing estimated patient numbers across Japan, the US, and China to analyze the overwhelming disease scale unique to the Chinese market. Visualizing the complex internal structure of multiple coexisting large markets to formulate optimal market entry scenarios.

Read more →

Promotion Strategy and Channel Optimization

Analyzing pharmaceutical manufacturers' reach to physicians and physicians' information gathering needs, enabling the development of communication strategies that resonate most effectively.

Optimal Hybrid Strategy Revealed by Trends in Information Sources

Analyzing trends in information sources physicians prioritize. Objectively visualizing the polarization of in-person needs and the role of digital by facility size and years of experience to build optimal omnichannel strategies tailored to target attributes.

Analyzing time-series trends in MR visit and digital channel coverage rates by major manufacturers. Visualizing overall digital shift trends and differences in activity coverage among top competitors to build effective channel strategies with optimized resource allocation.

Analyzing the recognition rates of MR visits, remote meetings, and e-detailing by major companies and Japanese firms in the US. Objectively visualizing differences in physician reach rates and channel composition to build effective global-standard promotion strategies.

Read more →